Literature DB >> 2572241

Convergence of hippocampal and dopaminergic input onto identified neurons in the nucleus accumbens of the rat.

S Totterdell1, A D Smith.   

Abstract

The hippocampal input to the nucleus accumbens was interrupted by an electrolytic lesion of the fimbria-fornix. Boutons degenerating as a result of this lesion were found in asymmetric synaptic contact with dendritic spines and shafts in the medial part of the nucleus accumbens. Dopaminergic fibres and terminals in this area, identified using an antibody to tyrosine hydroxylase, established symmetrical synaptic contacts with dendritic shafts, spines and somata. In material where neurons in the nucleus accumbens had been Golgi-impregnated, it was found that the hippocampal and dopaminergic inputs converge onto the same neurons, and that the post-synaptic targets could be either spiny or aspiny neurons. It has been suggested that hippocampal dysfunction is involved in schizophrenia and this convergence of input from the hippocampus onto the same neurons that are post-synaptic to the dopaminergic input, which presumably originates from neurons in the ventral tegmental area, may provide an anatomical basis for the therapeutic effects of neuroleptic drugs which are dopamine antagonists.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2572241

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  49 in total

1.  Coincident activation of NMDA and dopamine D1 receptors within the nucleus accumbens core is required for appetitive instrumental learning.

Authors:  S L Smith-Roe; A E Kelley
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  Slow phasic and tonic activity of ventral pallidal neurons during cocaine self-administration.

Authors:  David H Root; Anthony T Fabbricatore; Anthony P Pawlak; David J Barker; Sisi Ma; Mark O West
Journal:  Synapse       Date:  2011-11-03       Impact factor: 2.562

3.  Fornix deep brain stimulation circuit effect is dependent on major excitatory transmission via the nucleus accumbens.

Authors:  Erika K Ross; Joo Pyung Kim; Megan L Settell; Seong Rok Han; Charles D Blaha; Hoon-Ki Min; Kendall H Lee
Journal:  Neuroimage       Date:  2016-01-11       Impact factor: 6.556

4.  Response-reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core.

Authors:  A E Kelley; S L Smith-Roe; M R Holahan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

5.  Facilitated extinction of appetitive instrumental conditioning following excitotoxic lesions of the core or the medial shell subregion of the nucleus accumbens in rats.

Authors:  Helen H J Pothuizen; Joram Feldon; Benjamin K Yee
Journal:  Exp Brain Res       Date:  2006-01-24       Impact factor: 1.972

Review 6.  The nucleus accumbens and Pavlovian reward learning.

Authors:  Jeremy J Day; Regina M Carelli
Journal:  Neuroscientist       Date:  2007-04       Impact factor: 7.519

Review 7.  Ventral tegmental glutamate: a role in stress-, cue-, and cocaine-induced reinstatement of cocaine-seeking.

Authors:  Roy A Wise
Journal:  Neuropharmacology       Date:  2008-06-13       Impact factor: 5.250

8.  Electrophysiology of the hippocampal and amygdaloid projections to the nucleus accumbens of the rat: convergence, segregation, and interaction of inputs.

Authors:  A B Mulder; M G Hodenpijl; F H Lopes da Silva
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

Review 9.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

10.  Towards a reconceptualization of striatal interactions between glutamatergic and dopaminergic neurotransmission and their contribution to the production of movements.

Authors:  Hélène N David
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.